|
US5136019A
(en)
*
|
1989-05-24 |
1992-08-04 |
Sri International |
Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US7102999B1
(en)
*
|
1999-11-24 |
2006-09-05 |
Juniper Networks, Inc. |
Switching device
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20070258987A1
(en)
|
2000-11-28 |
2007-11-08 |
Seattle Genetics, Inc. |
Recombinant Anti-Cd30 Antibodies and Uses Thereof
|
|
AR048098A1
(es)
|
2004-03-15 |
2006-03-29 |
Wyeth Corp |
Conjugados de caliqueamicina
|
|
EP1747233A4
(en)
|
2004-05-06 |
2007-04-25 |
|
COMPOUNDS FOR SPECIFIC VIRAL TARGET
|
|
AR056857A1
(es)
*
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
EP2167963B1
(en)
|
2007-05-23 |
2019-04-17 |
Ventana Medical Systems, Inc. |
Polymeric carriers for immunohistochemistry and in situ hybridization
|
|
SG189817A1
(en)
|
2008-04-30 |
2013-05-31 |
Immunogen Inc |
Potent conjugates and hydrophilic linkers
|
|
KR101000067B1
(ko)
|
2008-12-30 |
2010-12-10 |
엘지전자 주식회사 |
고효율 태양전지용 레이저 소성장치 및 고효율 태양전지 제조방법
|
|
SI2528625T1
(sl)
|
2010-04-15 |
2013-11-29 |
Spirogen Sarl |
Pirolobenzodiazepini in njihovi konjugati
|
|
US20130244905A1
(en)
|
2010-07-06 |
2013-09-19 |
Ed Grabczyk |
Reporter for RNA Polymerase II Termination
|
|
CN110078789A
(zh)
|
2011-05-27 |
2019-08-02 |
Ambrx 公司 |
含有非天然氨基酸连接的海兔毒素衍生物的组合物、涉及该海兔毒素衍生物的方法及其用途
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
CA2850373C
(en)
|
2011-10-14 |
2019-07-16 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
BR112014009070B1
(pt)
|
2011-10-14 |
2021-11-23 |
Medimmune Limited |
Método de síntese e intermediários úteis na preparação de pirrolobenzo-diazepinas
|
|
CN103997893B
(zh)
|
2011-10-14 |
2019-04-12 |
西雅图基因公司 |
吡咯并苯并二氮杂卓和靶向结合物
|
|
EP2751111B1
(en)
|
2011-10-14 |
2017-04-26 |
MedImmune Limited |
Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative or autoimmune diseases
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
CN105142672B
(zh)
|
2012-10-23 |
2019-04-05 |
西纳福克斯股份有限公司 |
经修饰的抗体、抗体-缀合物及其制备方法
|
|
JP6847388B2
(ja)
|
2013-03-15 |
2021-03-31 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
生物活性分子、そのコンジュゲート、及び治療用途
|
|
US9260182B2
(en)
*
|
2013-10-30 |
2016-02-16 |
Westjet Airlines Ltd. |
Integrated communication and application system for aircraft
|
|
LT3068776T
(lt)
*
|
2013-11-13 |
2019-08-12 |
Vertex Pharmaceuticals Incorporated |
Gripo virusų replikacijos inhibitoriai
|
|
JP6712428B2
(ja)
*
|
2014-02-04 |
2020-06-24 |
コントラフェクト コーポレイション |
インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法
|
|
US10639370B2
(en)
*
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
TW201620932A
(zh)
*
|
2014-03-27 |
2016-06-16 |
建南德克公司 |
抗－ｂ型流感病毒血球凝集素抗體及其使用方法
|
|
US20160175224A1
(en)
*
|
2014-12-19 |
2016-06-23 |
Johnson & Johnson Consumer Companies, Inc. |
Antiperspirant composition
|
|
TWI702229B
(zh)
|
2014-12-19 |
2020-08-21 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
SG11201708721XA
(en)
*
|
2015-04-28 |
2017-11-29 |
Shionogi & Co |
Substituted polycyclic pyridone derivative and prodrug thereof
|
|
SG11201804348SA
(en)
*
|
2015-12-15 |
2018-06-28 |
Shionogi & Co |
Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug
|
|
CN106589126A
(zh)
*
|
2016-12-07 |
2017-04-26 |
中国药科大学 |
一种抗人cd24抗体突变体的设计及其应用
|
|
CN111936517B
(zh)
|
2018-01-26 |
2025-04-18 |
瑞泽恩制药公司 |
抗tmprss2抗体和抗原结合片段
|
|
US20210393786A1
(en)
*
|
2018-07-26 |
2021-12-23 |
Purdue Research Foundation |
Small molecule ligand-targeted drug conjugates for anti-influenza chemotherapy and immunotherapy
|
|
TWI861205B
(zh)
*
|
2019-09-06 |
2024-11-11 |
美商席達拉醫療有限公司 |
用於治療病毒感染之組合物及方法
|